Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akslen, LA, and VA LiVolsi. 2000. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 88:1902–1908.
Bachelot, A, AF Cailleux, M Klain, E Baudin, M Ricard, N Bellon, B Caillou, JP Travagli, and M Schlumberger. 2002. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 12:707–711.
Cailleux, AF, E Baudin, JP Travagli, M Ricard, and M Schlumberger. 2000. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175–178.
Gardner, RE, RM Tuttle, KD Burman, S Haddady, C Truman, YH Sparling, L Wartofsky, RB Sessions, and MD Ringel. 2000. Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 126:309–312.
Mazzaferri, EL, RJ Robbins, CA Spencer, LE Braverman, F Pacini, L Wartofsky, BR Haugen, SI Sherman, DS Cooper, GD Braunstein, S Lee, TF Davies, BM Arafah, PW Ladenson, and A Pinchera. 2003. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433–1441.
Prendiville, S, KD Burman, MD Ringel, BM Shmookler, ZE Deeb, K Wolfe, N Azumi, L Wartofsky, and RB Sessions. 2000. Tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck Surg 122:352–357.
Rouxel, A, G Hejblum, MO Bernier, PY Boelle, F Menegaux, G Mansour, C Hoang, A Aurengo, and L Leenhardt. 2004. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 89:5362–5368.
Schlumberger, M, G Berg, O Cohen, L Duntas, F Jamar, B Jarzab, E Limbert, P Lind, F Pacini, C Reiners, FS Franco, A Toft, and WM Wiersinga. 2004. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150:105–112.
Toubeau, M, C Touzery, P Arveux, G Chaplain, G Vaillant, A Berriolo, JM Riedinger, C Boichot, A Cochet, and F Brunotte. 2004. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 45:988–994.
Wenig, BN, LDR Thompson, CF Adair, B Shmookler, and CS Heffess. 1998. Thyroid papillary carcinoma of columnar cell type—a clinicopathologic study of 16 cases. Cancer 82:740–753.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Mazzaferri, E.L. (2005). An Overview of Follow-Up of Differentiated Thyroid Cancer. In: Amdur, R.J., Mazzaferri, E.L. (eds) Essentials of Thyroid Cancer Management. Springer, Boston, MA. https://doi.org/10.1007/0-387-25714-4_37
Download citation
DOI: https://doi.org/10.1007/0-387-25714-4_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25713-6
Online ISBN: 978-0-387-25714-3
eBook Packages: MedicineMedicine (R0)